China De Xiao Quan Care Group Co., Ltd
China De Xiao Quan Care Group Co., Ltd
Your view on CDXQ
Overview
What the company does, where it operates, and who runs it.
About China De Xiao Quan Care Group Co., Ltd
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Chunsheng Qin
- Headquarters
- 42 Mott Street, New York City, NY, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Chunsheng Qin
- Headquarters
- 42 Mott Street, New York City, NY, US
China De Xiao Quan Care Group Co., Ltd does not have significant operations. Previously, it was involved in the development and commercialization of technologies related to the medical marijuana market. The company was formerly known as Nhale, Inc. The company was incorporated in 2012 and is based in New York, New York.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for China De Xiao Quan Care Group Co., Ltd, and the rating behind it. CDXQ last traded at $0.0002, 0.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for China De Xiao Quan Care Group Co., Ltd. Starting points for China De Xiao Quan Care Group Co., Ltd: P/E 0.0, EPS $0.04, beta -45.33 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for China De Xiao Quan Care Group Co., Ltd. China De Xiao Quan Care Group Co., Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for China De Xiao Quan Care Group Co., Ltd. Trailing twelve-month EPS for China De Xiao Quan Care Group Co., Ltd stands at $0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for China De Xiao Quan Care Group Co., Ltd. China De Xiao Quan Care Group Co., Ltd has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
China De Xiao Quan Care Group Co., Ltd valued side by side against its closest peers. China De Xiao Quan Care Group Co., Ltd is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold China De Xiao Quan Care Group Co., Ltd, and how their positions are changing. At a $6,000 market value, institutional positions materially move China De Xiao Quan Care Group Co., Ltd's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by China De Xiao Quan Care Group Co., Ltd executives and directors. Shares of China De Xiao Quan Care Group Co., Ltd have traded between $0.0001 and $0.0006 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming China De Xiao Quan Care Group Co., Ltd. China De Xiao Quan Care Group Co., Ltd is a $6,000 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming China De Xiao Quan Care Group Co., Ltd. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for China De Xiao Quan Care Group Co., Ltd. Coverage tracks China De Xiao Quan Care Group Co., Ltd within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.